Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Wells

Showing results (111-120 of 281) with videos related to

Pageof 29
Sort By:
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patientsMounzer Agha, Maggie Blake, Charles Chilleo, et al.
International Journal of Molecular Sciences|May 28, 2019
Adult Stem Cell Functioning in the Tumor Micro-EnvironmentYuhan Jiang, Alan Wells, Kyle Sylakowski, et al.
Tissue Engineering. Part A|April 2, 2013
The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasLMelanie Rodrigues, Cecelia C Yates, Austin Nuschke, et al.
Journal of Cellular Physiology|August 22, 2007
Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signalingAnand Krishnan V Iyer, Kien T Tran, Linda Griffith, et al.
Open Forum Infectious Diseases|August 2, 2021
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking EraMounzer E Agha, Maggie Blake, Charles Chilleo, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|November 24, 2004
Celosia argentea Linn. leaf extract improves wound healing in a rat burn wound modelKulasekaran S Priya, Gnanamani Arumugam, Bhuvaneswari Rathinam, et al.
Stem Cell Research & Therapy|December 2, 2016
Mesenchymal stem cells/multipotent stromal cells (MSCs) are glycolytic and thus glucose is a limiting factor of in vitro models of MSC starvationAustin Nuschke, Melanie Rodrigues, Albin W Wells, et al.
Cell Transplantation|April 25, 2012
Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligandMelanie Rodrigues, Omari Turner, Donna Stolz, et al.
BMC Cancer|July 9, 2016
Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cellsMin Yang, Bo Ma, Hanshuang Shao, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2002
Growth factor-induced cell motility in tumor invasionAlan Wells, Jareer Kassis, James Solava, et al.
Pageof 29

Showing results (111-120 of 281) with videos related to

Sort By:
Pageof 29
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patientsMounzer Agha, Maggie Blake, Charles Chilleo, et al.
International Journal of Molecular Sciences|May 28, 2019
Adult Stem Cell Functioning in the Tumor Micro-EnvironmentYuhan Jiang, Alan Wells, Kyle Sylakowski, et al.
Tissue Engineering. Part A|April 2, 2013
The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasLMelanie Rodrigues, Cecelia C Yates, Austin Nuschke, et al.
Journal of Cellular Physiology|August 22, 2007
Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signalingAnand Krishnan V Iyer, Kien T Tran, Linda Griffith, et al.
Open Forum Infectious Diseases|August 2, 2021
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking EraMounzer E Agha, Maggie Blake, Charles Chilleo, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|November 24, 2004
Celosia argentea Linn. leaf extract improves wound healing in a rat burn wound modelKulasekaran S Priya, Gnanamani Arumugam, Bhuvaneswari Rathinam, et al.
Stem Cell Research & Therapy|December 2, 2016
Mesenchymal stem cells/multipotent stromal cells (MSCs) are glycolytic and thus glucose is a limiting factor of in vitro models of MSC starvationAustin Nuschke, Melanie Rodrigues, Albin W Wells, et al.
Cell Transplantation|April 25, 2012
Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligandMelanie Rodrigues, Omari Turner, Donna Stolz, et al.
BMC Cancer|July 9, 2016
Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cellsMin Yang, Bo Ma, Hanshuang Shao, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2002
Growth factor-induced cell motility in tumor invasionAlan Wells, Jareer Kassis, James Solava, et al.
Pageof 29